Premier Integrated Labs is leading efforts to advance early diagnosis and understanding of Alzheimer’s disease in Malaysia – a critical step in improving outcomes for patients and families affected by the condition.
On 22 April 2025, Premier Integrated Labs (PIL) launched a nationwide Continuing Medical Education tour in Penang, in collaboration with Mayo Clinic Laboratories and Eisai Co., Ltd.
The inaugural event brought together neurology specialists from both public and private hospitals to spotlight the importance of early detection and biomarker-based testing for Alzheimer’s.
Dr Jaron L from Mayo Clinic Laboratories highlighted the benefits of biomarker-driven diagnostics, while Dr Yew Keong Ng from Eisai shared insights into the evolving diagnostics landscape in Malaysia. The strong turnout underscored the clinical community’s shared commitment to tackling one of the most pressing neurological challenges of our time.
Separately, PIL also participated in a strategic session with YBhg Datuk Dr Muhammad Radzi Abu Hassan, former Director-General of Health, Malaysia Ministry of Health, to present updates on the ongoing study “Whole Exome Sequencing in Late-Onset Alzheimer’s Disease (LOAD) in Peninsular Malaysia.” The study seeks to uncover genomic markers and better understand the clinical characteristics of LOAD among local patients.
Representing PIL were CEO Hareeff Muhammed, Sayyidi Hamzi, and Dr Zubaidah, alongside collaborators Dr Hans Prakash (Institute for Medical Research) and Dr Cheah Wee Kooi (Hospital Taiping).
These initiatives reflect PIL’s dedication to fostering clinical collaboration, advancing diagnostics, and driving evidence-based care in the fight against Alzheimer’s disease.
Related Stories
IHH Singapore Honoured for Corporate Giving Excellence
Gleneagles JPMC Strengthens Cross-Border Healthcare Collaboration
East Meets West in Holistic Hypertension Care by Parkway Shenton
Parkway Shenton and Eu Yan Sang have deepened their collaboration with the launch of their Integrative Clinical Care Protocol for Hypertension, an innovative collaboration combining Western and traditional Chinese medicine (TCM).
From Patient to Pillar of Support: A Cancer Survivor’s Journey at Acibadem Kent Hospital
When Neslihan Ergin was diagnosed with breast cancer in early 2020, she never imagined that the hospital where she received treatment would one day become her workplace and her new purpose.
Gleneagles JPMC Spotlights Cardiac Excellence at BSI International Expo in Jakarta
Our world-class tertiary cardiac centre in Brunei highlighted its clinical expertise and patient-first approach at the BSI International Expo 2025 in Jakarta.
Pantai Hospital Ipoh Achieves Surgical Milestone with First Minimally Invasive Thymectomy
With the successful completion of its first minimally invasive surgical procedure to remove the thymus gland, Pantai Hospital Ipoh has taken a major step forward in patient-centred care.
